financetom
Business
financetom
/
Business
/
AppLovin Shares Fall 20% Following Muddy Waters Report On Alleged Platform Violations: What's Going On?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
AppLovin Shares Fall 20% Following Muddy Waters Report On Alleged Platform Violations: What's Going On?
Mar 27, 2025 1:54 PM

AppLovin Corp ( APP ) shares were trading lower Thursday after short seller Muddy Waters issued a critical report on the company. Benzinga has reached out to AppLovin ( APP ) for comment on the Muddy Waters report.

What To Know: Muddy Waters alleged that its e-commerce operations rely heavily on retargeting, provide low incremental value and violate the terms of service of major digital ad platforms.

Muddy Waters stated that approximately 52% of AppLovin's ( APP ) e-commerce conversions come from retargeting, while only 25%-35% of sales are truly incremental. The report also alleged AppLovin ( APP ) extracts proprietary user data from major platforms, including Meta, Google and TikTok, to build artificial user graphs, giving it an unfair advantage in ad auctions.

The short seller further alleged AppLovin's ( APP ) techniques involve persistent identity graphs ("PIGs") to retarget high-value users, making its actions difficult to detect. Additionally, Muddy Waters reported a 23% churn rate among AppLovin's ( APP ) e-commerce beta advertisers, contradicting the company's prior statements of near-zero churn.

If the allegations are accurate, Muddy Waters suggested AppLovin ( APP ) could face the risk of deplatforming, similar to past cases like Cheetah Mobile.

AppLovin ( APP ) has yet to respond to the report.

APP Price Action: Applovin ( APP ) closed Thursday down 20.12% at $261.70, according to Benzinga Pro.

Read Next:

Stocks Slide As Auto Tariffs Boost Tesla, Rivian And Hit GM, Ford: What’s Driving Markets Thursday?

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Kraft-Heinz pulls key Lunchables meals from U.S. free- and low-cost school lunch program
Kraft-Heinz pulls key Lunchables meals from U.S. free- and low-cost school lunch program
Nov 12, 2024
NEW YORK (Reuters) - Kraft Heinz is no longer making its packaged lunch brand Lunchables for low-income students receiving free and reduced-priced meals from a federal program, according to a company statement, the latest blow to one of the company's most iconic products. Chicago-based Kraft Heinz announced plans to sell to the school lunch program early last year at an...
Exclusive-Pfizer explores sale of hospital drugs unit, sources say
Exclusive-Pfizer explores sale of hospital drugs unit, sources say
Nov 12, 2024
NEW YORK (Reuters) - Pfizer ( PFE ) is exploring the sale of its hospital drugs unit, as the drugmaker, which has been under pressure from activist investor Starboard Value, looks to divest non-core assets, according to three people familiar with the matter. The unit, now called Pfizer Hospital, was formed after Pfizer ( PFE ) bought Hospira for about...
Resmed Insider Sold Shares Worth $3,615,821, According to a Recent SEC Filing
Resmed Insider Sold Shares Worth $3,615,821, According to a Recent SEC Filing
Nov 12, 2024
05:41 PM EST, 11/12/2024 (MT Newswires) -- Michael J. Farrell, Chief Executive Officer, on November 07, 2024, sold 14,683 shares in Resmed ( RMD ) for $3,615,821. Following the Form 4 filing with the SEC, Farrell has control over a total of 468,344 shares of the company, with 464,254 shares held directly and 4,090 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/943819/000112760224027086/xslF345X05/form4.xml ...
ICU Medical Q3 Adjusted Earnings, Revenue Increase; 2024 EPS Guidance Raised
ICU Medical Q3 Adjusted Earnings, Revenue Increase; 2024 EPS Guidance Raised
Nov 12, 2024
05:15 PM EST, 11/12/2024 (MT Newswires) -- ICU Medical ( ICUI ) reported Q3 adjusted earnings late Tuesday of $1.59 per diluted share, up from $1.57 a year earlier. Analysts polled by Capital IQ expected $1.25. Revenue for the quarter ended Sept. 30 was $589.1 million, up from $553.3 million a year earlier. Analysts surveyed by Capital IQ expected $576.7...
Copyright 2023-2026 - www.financetom.com All Rights Reserved